Axa wins final regulatory approval for $15.3bn XL deal
  • X
  • LinkedIn
  • Email
  • Show more sharing options
  • Copy Link URLCopied!
  • Print
  • X
  • LinkedIn
  • Email
© 2024 Insider International Limited, company number 15236286, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian Group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings

Axa wins final regulatory approval for $15.3bn XL deal

Ted Bunker
11 September 2018
  • X
  • LinkedIn
  • Email
  • Show more sharing options
  • Copy Link URLCopied!
  • Print
  • X
  • LinkedIn
  • Email
700-x-410-crop-of-axa-exec-rings-opening-bell-on-nyse-at-10-may-ipo-nyse-tweet.jpg

Axa plans to close its $15.3bn acquisition of XL Group on Wednesday after receiving final regulatory approvals for that step, the company said today.

Request a free trial:

Fuel a smarter strategy with our actionable market intelligence

    • Gain a competitive edge and accelerate decision-making
    • Be empowered by insights that transform confusion to clarity
    • Uncover growth opportunities and prepare for potential threats
Request a free trial Already a subscriber? Login now

Topics

NewsAxaM&A
TB
Ted Bunker
Gift this article